Dieter Lang

2.8k citations

35 papers · 1.9k indexed · 1 hit paper · h-index 22

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management

Papers in

Pharmacology 14
- Pharmacogenetics and Drug Metabolism 14
Biochemistry 4
- Eicosanoids and Hypertension Pharmacology 4

Co-authors: Allan E. Rettie R. Böcker Thomas Schwarz Wolfgang Mueck Dagmar Kubitza Bernard Testa Jens Kunze Andreas H. Göller
Journals: Drug Metabolism and Disposition (7 papers)Chemical Research in Toxicology (4 papers)ChemMedChem (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Archives of Toxicology (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Dieter Lang

35 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Predicting drug metabolism: experiment and/or computation? 2015 · 359 citations

Peers

Countries citing papers authored by Dieter Lang

Since Specialization

Citations

This map shows the geographic impact of Dieter Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Lang more than expected).

Fields of papers citing papers by Dieter Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Lang. The network helps show where Dieter Lang may publish in the future.

Co-authors

The 25 scholars most cited alongside Dieter Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dieter Lang Line = papers co-authored together Dieter Lang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites Current Drug Metabolism ·Simone I. Schulz, Dieter Lang, Gabriele Schmuck, Michael Gerisch, Michaela Bairlein, Robert E. Fricke, Heino Staß	2023	1
2	Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders Journal of Medicinal Chemistry ·Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez, Henrik Teller, Pascal Ellerbrock, Katharina Meier, Stefan Heitmeier, Adrian Tersteegen, Jan Stampfuss, Dieter Lang, Karl‐Heinz Schlemmer, Martina Schaefer, Kersten M. Gericke, Tom Kinzel, Daniel Meibom, Mathias V. Schmidt, Christoph Gerdes, Markus Follmann, Alexander Hillisch	2023	14
3	Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans European Journal of Drug Metabolism and Pharmacokinetics ·Isabel Piel, Anna Engelen, Dieter Lang, Simone I. Schulz, Michael Gerisch, Christine Brase, Wiebke Janssen, Lukas Fiebig, Stefan Heitmeier, Friederike Kanefendt	2023	12
4	Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox Chemical Research in Toxicology ·Dieter Lang, Simone I. Schulz, Isabel Piel, Dieudonné Tshitenge Tshitenge, Heino Staß	2022	5
5	Inhibition of 6-formylindolo[3,2-b]carbazole metabolism sensitizes keratinocytes to UVA-induced apoptosis: Implications for vemurafenib-induced phototoxicity Redox Biology ·Katharina M. Rolfes, Natalie C. Sondermann, Christian Vogeley, Julien Dairou, Viola Gilardino, Ragnhild Wirth, Stephan Meller, Bernhard Homey, Jean Krutmann, Dieter Lang, Motoki Nakamura, Thomas Haarmann‐Stemmann	2021	11
6	Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response Environment International ·Christian Vogeley, Natalie C. Sondermann, Selina Woeste, Afaque A. Momin, Viola Gilardino, Frederick Hartung, Markus Heinen, Sophia K. Maaß, Melina Mescher, Marius Pollet, Katharina M. Rolfes, Christoph F. A. Vogel, Andrea Rossi, Dieter Lang, Stefan T. Arold, Motoki Nakamura, Thomas Haarmann‐Stemmann	2021	37
7	Genotoxicity Assessment of Drug Metabolites in the Context of MIST and Beyond Chemical Research in Toxicology ·Andreas Zeller, Alessandro Brigo, Andreas Brink, Melanie Guérard, Dieter Lang, Wolfgang Muster, Frank Runge, Andreas Sutter, Esther Vock, Joerg Wichard, Simone Schadt	2019	9
8	Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans Chemical Research in Toxicology ·Dieter Lang, Martin Radtke, Michaela Bairlein	2019	46
9	Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro Drug Metabolism and Disposition ·Michael Gerisch, Roland Heinig, Anna Engelen, Dieter Lang, Peter Kolkhof, Martin Radtke, Johannes Platzek, Kai Lovis, Gabriele Rohde, Thomas Schwarz	2018	58
10	Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers Cancer Chemotherapy and Pharmacology ·Michael Gerisch, Thomas Schwarz, Dieter Lang, Gabriele Rohde, Stefanie Reif, Isabelle Genvresse, Susanne Reschke, Dorina van der Mey, Camille Granvil	2017	13
11	Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects Cancer Chemotherapy and Pharmacology ·Michael Gerisch, Frank‐Thorsten Hafner, Dieter Lang, Martin Radtke, Konstanze Diefenbach, Adriaan Cleton, John Lettieri	2017	34
12	Sorafenib Hepatobiliary Disposition: Mechanisms of Hepatic Uptake and Disposition of Generated Metabolites Drug Metabolism and Disposition ·Brandon Swift, Noelia Nebot, Jin Kyung Lee, Tianxiang Han, William R. Proctor, Dhiren R. Thakker, Dieter Lang, Martin Radtke, Mark Jean Gnoth, Kim L. R. Brouwer	2013	52
13	In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans Drug Metabolism and Disposition ·Dieter Lang, C. Freudenberger, Corinna Weinz	2009	92
14	Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist Bioorganic & Medicinal Chemistry Letters ·Stefan Weigand, Hilmar Bischoff, Elke Dittrich‐Wengenroth, Heike Heckroth, Dieter Lang, Andrea Vaupel, Michael J. Woltering	2005	25
15	Immunoquantitation of FMO1 in Human Liver, Kidney, and Intestine Drug Metabolism and Disposition ·Catherine K. Yeung, Dieter Lang, Kenneth E. Thummel, Allan E. Rettie	2000	106
16	In vitro evaluation of potential in vivo probes for human flavin‐containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms British Journal of Clinical Pharmacology ·Dieter Lang, Allan E. Rettie	2000	57
17	Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecenoic acid Chemico-Biological Interactions ·Xiangming Guan, Michael B. Fisher, Dieter Lang, Yi-Min Zheng, Dennis R. Koop, Allan E. Rettie	1998	41
18	Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines. Drug Metabolism and Disposition ·Wolfgang A. Schmalix, Dieter Lang, Achim Schneider, R. Böcker, Helmut Greim, Johannes Doehmer	1996	27
19	A convenient method to discriminate between cytochrome P450 enzymes and flavin-containing monooxygenases in human liver microsomes Archives of Toxicology ·A. Grothusen, J. Hardt, Lars Bräutigam, Dieter Lang, R. Böcker	1996	59
20	In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans. Drug Metabolism and Disposition ·Dieter Lang, D Criegee, A. Grothusen, R W Saalfrank, R. Böcker	1996	59

About Dieter Lang

Dieter Lang is a scholar working on Pharmacology, Biochemistry, Oncology, Transplantation and Genetics, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (10 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Vitamin K Research Studies (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Biochemical and Molecular Research (3 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Pharmacology (603 citations), Internal Medicine (247 citations), Cardiology and Cardiovascular Medicine (410 citations), Computational Theory and Mathematics (245 citations) and Biochemistry (110 citations). Dieter Lang has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Allan E. Rettie, R. Böcker, Thomas Schwarz, Wolfgang Mueck, Dagmar Kubitza, Bernard Testa, Jens Kunze, Andreas H. Göller, Ian D. Wilson and Johannes Kirchmair. Their work appears in journals such as Drug Metabolism and Disposition, Chemical Research in Toxicology, ChemMedChem, Cancer Chemotherapy and Pharmacology and Archives of Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact